Table 3.
CHARM‐Added | CHARM‐Alternative | |||||
---|---|---|---|---|---|---|
Estimate | 95% CI | P‐value | Estimate | 95% CI | P‐value | |
H R GL | 0.683 | 0.57‐0.82 | <0.0001 | 0.687 | 0.55‐0.86 | 0.0008 |
H R JFM1 | 0.650 | 0.53‐0.80 | <0.0001 | 0.608 | 0.49‐0.76 | <0.0001 |
H R CPH | 0.842 | 0.72‐0.98 | 0.029 | 0.847 | 0.71‐1.02 | 0.072 |
H R JFM2 | 0.839 | 0.70‐1.01 | 0.065 | 0.851 | 0.68‐1.07 | 0.172 |
θ (SE) | 3.751 (0.208) | 3.452 (0.207) | ||||
α (SE) | 0.688 (0.054) | 0.846 (0.069) |
CHARM, Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity.